ORIGINAL ARTICLE

Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management

J M Brooks¹, J N Travadi¹, S K Patole^*1, D A Doherty² and K Simmer^*1

¹ Women’s and Children’s Health Service, Western Australia and *University of Western Australia
² Women and Infants Research Foundation and University of Western Australia

Correspondence to:
Correspondence to:
Dr Patole
Department of Neonatal Paediatrics, King Edward Memorial Hospital, Bagot Road, Subiaco, Western Australia 6008; Sanjay.Patole{at}health.wa.gov.au

Background: Surgical ligation of patent ductus arteriosus (PDA) is widely practised in preterm infants despite no clear evidence that this improves outcomes. Geographical isolation meant that ductal ligation was not an option in King Edward Memorial Hospital until recently.

Objective: A retrospective data analysis to test the hypothesis that outcomes of infants with persistent PDA were no worse than those of infants with no significant duct or a duct that closed after medical treatment.

Patients and Methods: A total of 252 infants (gestation 28 weeks) born between 1 January 2000 and 30 June 2002 were divided into three groups: group 1, no significant PDA (n = 154); group 2, significant PDA which closed after medical treatment (n = 65); group 3, significant PDA remaining patent after medical treatment (n = 33). A significant PDA was defined by a left atrium to aortic root ratio of >1.4 or a ductal diameter >1.5 mm with a left to right shunt.

Results: Twenty four (10%) infants died at median (interquartile range) 15.5 (9–35) days. After adjustment for gestational age, relative to group 1, the infants from group 3 were at a 4.02 times increased risk of death (95% confidence interval 1.12 to 14.51). There was no significant difference between groups in the incidence of chronic lung disease, chronic lung disease or death, necrotising enterocolitis, intraventricular haemorrhage, duration of oxygen, or hospital stay.

Conclusion: Mortality was higher in infants with a persistent PDA, but other morbidities were not significantly different. A randomised trial is needed to determine whether surgical ligation will reduce mortality in such infants.

Abbreviations: CLD, chronic lung disease; CRIB, clinical risk index for babies; IVH, intraventricular haemorrhage; NEC, necrotising enterocolitis; PDA, patent ductus arteriosus

Keywords: patent ductus arteriosus; surgical ligation; mortality; chronic lung disease

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Vida, V. L., Lago, P., Salvatori, S., Boccuzzo, G., Padalino, M. A., Milanesi, O., Speggiorin, S., Stellin, G. (2009). Is there an optimal timing for surgical ligation of patent ductus arteriosus in preterm infants?. Ann. Thorac. Surg. 87: 1509-1516 [Abstract] [Full Text]  
• Noori, S., McCoy, M., Friedlich, P., Bright, B., Gottipati, V., Seri, I., Sekar, K. (2009). Failure of Ductus Arteriosus Closure Is Associated With Increased Mortality in Preterm Infants. Pediatrics 123: e138-e144 [Abstract] [Full Text]  
• El-Khuffash, A, Barry, D, Walsh, K, Davis, P G, Molloy, E J (2008). Biochemical markers may identify preterm infants with a patent ductus arteriosus at high risk of death or severe intraventricular haemorrhage. Arch. Dis. Child. Fetal Neonatal Ed. 93: F407-F412 [Abstract] [Full Text]  
• Gaca, A. M., Jaggers, J. J., Dudley, L. T., Bisset, G. S. III (2008). Repair of Congenital Heart Disease: A Primer--Part 2. Radiology 248: 44-60 [Abstract] [Full Text]  
• Roberts, P., Adwani, S., Archer, N., Wilson, N. (2007). Catheter closure of the arterial duct in preterm infants. Arch. Dis. Child. Fetal Neonatal Ed. 92: F248-F250 [Abstract] [Full Text]  
• Chorne, N., Leonard, C., Piecuch, R., Clyman, R. I. (2007). Patent Ductus Arteriosus and Its Treatment as Risk Factors for Neonatal and Neurodevelopmental Morbidity. Pediatrics 119: 1165-1174 [Abstract] [Full Text]  
• Patole, S K, Kumaran, V, Travadi, J N, Brooks, J M, Doherty, D A (2007). Does patent ductus arteriosus affect feed tolerance in preterm neonates?. Arch. Dis. Child. Fetal Neonatal Ed. 92: F53-F55 [Abstract] [Full Text]  
• Manzar, S. (2006). High-Dose Indomethacin for Patent Ductus Arteriosus Closure: How Strong Is the Evidence?. Pediatrics 117: 1863-1863 [Full Text]  
• Sperandio, M., Beedgen, B., Linderkamp, O. (2006). High-Dose Indomethacin for Patent Ductus Arteriosus Closure: How Strong Is the Evidence?: In Reply. Pediatrics 117: 1863-1864 [Full Text]  
• Fowlie, P W (2005). Managing the baby with a patent ductus arteriosus. More questions than answers?. Arch. Dis. Child. Fetal Neonatal Ed. 90: F190-f190 [Full Text]